These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7060073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P, Schmidt P, Zazgornik J, Kopsa H, Minar E.
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Calcium oxalate stones and hyperoxaluria secondary to treatment with pyridoxilate].
    Wolf C, Maistre-Charransol G, Barthélémy C, Thomas E, Thomas J, Arvis G, Steg A.
    Ann Urol (Paris); 1985; 19(5):313-7. PubMed ID: 4083839
    [Abstract] [Full Text] [Related]

  • 10. The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis.
    Takasaki E, Shimano E.
    Invest Urol; 1967 Nov; 5(3):303-12. PubMed ID: 6073639
    [No Abstract] [Full Text] [Related]

  • 11. [Oxaluria, nonfamilial hyperoxaluric form of oxalic lithiasis].
    Desgrez P, Thomas J, David-Issartel R.
    J Urol Nephrol (Paris); 1968 Sep; 74(9):685-9. PubMed ID: 5718185
    [No Abstract] [Full Text] [Related]

  • 12. [Inhibition of calcium oxalate urolithiasis with pyridoxine and magnesium in an experiment].
    Krídl J, Zvara V, Revúsová V, Gratzlová J, Ondrus B.
    Bratisl Lek Listy; 1984 Jan; 81(1):21-8. PubMed ID: 6692164
    [No Abstract] [Full Text] [Related]

  • 13. [Experimental evidence of magnesium salts for treatment of calcium oxalate nephrolithiasis in an animal model based on sodium oxalate and a cyclooxygenase 2 selective inhibitor].
    Spasov AA, Iezhitsa IN, Kharitonova MV, Kravchenko MS, Snigur GL, Pisarev VB.
    Patol Fiziol Eksp Ter; 2013 Jan; (2):50-5. PubMed ID: 24000715
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of recurrent calcium stones: diet versus drugs.
    Jaeger P.
    Miner Electrolyte Metab; 1994 Jan; 20(6):410-3. PubMed ID: 7783704
    [Abstract] [Full Text] [Related]

  • 16. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones.
    Gershoff SN, Prien EL.
    Am J Clin Nutr; 1967 May; 20(5):393-9. PubMed ID: 6023850
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS, Farooqui S, Talwar HS, Thind SK, Nath R, Rajendran L, Bapna BC.
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.